Using Argentine Tango to help breast cancer survivors manage chemotherapy side effects
Dance-based Avenues to Advance Nonpharmacologic treatment of Chemotherapy Effects (DAANCE): a multicenter trial
This study is looking at how dancing the Adapted Argentine Tango can help breast cancer survivors who are dealing with nerve pain from chemotherapy, making it easier for them to move and feel better while having fun and connecting with others.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Ohio State University NIH-funded |
| Lab location | 1 site (Columbus, UNITED STATES) |
| Project ID | NIH-10982211 on NIH RePORTER |
What this research studies
This research investigates the effects of partnered Adapted Argentine Tango as a nonpharmacologic intervention for breast cancer survivors experiencing chemotherapy-induced neuropathy. The study aims to improve mobility and alleviate symptoms through engaging in moderate-intensity dance, which combines physical activity with social interaction. Participants will be involved in a multi-center clinical trial, where their progress will be monitored through patient-reported outcomes and clinical assessments. The approach emphasizes creativity and caregiver involvement to enhance the overall experience and effectiveness of the intervention.
Who could benefit from this research
Good fit: Ideal candidates for this research are breast cancer survivors who are experiencing chemotherapy-induced neuropathy and have mobility deficits.
Not a fit: Patients who are not breast cancer survivors or those without chemotherapy-induced neuropathy may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could significantly improve the quality of life for breast cancer survivors by reducing pain and enhancing mobility.
How similar studies have performed: Previous research has shown that Argentine Tango is a feasible and enjoyable activity for older survivors, indicating potential for success in this novel application.
Where this research is happening
Columbus, UNITED STATES
- Ohio State University — Columbus, United States (Active)
Researchers
- Principal investigator: Worthen-Chaudhari, Lise C. — Ohio State University
- Study coordinator: Worthen-Chaudhari, Lise C.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.